Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.65B P/E 35.51 EPS this Y - Ern Qtrly Grth 3.00%
Income 238M Forward P/E - EPS next Y - 50D Avg Chg -4.00%
Sales 1.93B PEG - EPS past 5Y - 200D Avg Chg 3.00%
Dividend 1.00% Price/Book 6.63 EPS next 5Y - 52W High Chg -11.00%
Recommedations - Quick Ratio 1.69 Shares Outstanding 377.74M 52W Low Chg 27.00%
Insider Own 1.95% ROA 7.74% Shares Float 371.46M Beta 0.58
Inst Own 60.69% ROE 14.52% Shares Shorted/Prior -/- Price 28.05
Gross Margin 51.96% Profit Margin 12.35% Avg. Volume 5,483 Target Price -
Oper. Margin 17.59% Earnings Date - Volume 220 Change 0.00%
About HALMA

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.